Glatiramer acetate (Copaxone) ๐
๐ About
Always check the BNF link here.
- ๐ฏ Immunomodulator used in relapsingโremitting multiple sclerosis (RRMS).
- Can reduce relapse frequency by ~30% in early treatment years.
- Self-administered by subcutaneous injection.
โ๏ธ Action
- Polypeptide that mimics myelin basic protein.
- Crosses the bloodโbrain barrier โ alters immune response.
- Shifts immune balance toward Th2 anti-inflammatory cells, reducing demyelination.
๐ Indications
- Relapsingโremitting multiple sclerosis (RRMS).
- Not effective in progressive forms of MS.
๐ Interactions
- No major interactions identified.
- โ ๏ธ Use caution if combined with other immunomodulators/immunosuppressants.
โ ๏ธ Cautions
- Injection should only be given after patient training.
- Monitor for immediate post-injection reactions (flushing, chest tightness, dyspnoea).
- See BNF for full cautions.
โ Contraindications
- ๐ซ Hypersensitivity to glatiramer acetate or mannitol.
๐ฅ Side Effects
- ๐ Injection site reactions: erythema, pain, pruritus, lipoatrophy.
- ๐ซ Dyspnoea, flushing, transient chest pain.
- โค๏ธ Palpitations, vasodilatation.
- ๐ฆ Lymphadenopathy, hypersensitivity reactions.
- ๐ฉธ Rare: thrombocytopenia, arthralgia.
๐ Dose
- 20 mg SC once daily OR 40 mg SC three times per week (โฅ48 hrs apart).
- Keep refrigerated; allow to reach room temperature before injection.